Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
暂无分享,去创建一个
[1] D. Spiegelman,et al. Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period , 2006, Cancer Epidemiology Biomarkers & Prevention.
[2] B. Rosner,et al. Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer , 2004, Cancer Research.
[3] R. Glynn,et al. Methods to evaluate risks for composite end points and their individual components. , 2004, Journal of clinical epidemiology.
[4] L. Schuler,et al. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor α and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[5] K. Liby,et al. Prolactin Overexpression by MDA-MB-435 Human Breast Cancer Cells Accelerates Tumor Growth , 2003, Breast Cancer Research and Treatment.
[6] S. Hankinson,et al. The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.
[7] S. Shousha,et al. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. , 2001, Journal of clinical pathology.
[8] P. Kelly,et al. Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression. , 2001, The Journal of clinical endocrinology and metabolism.
[9] C. Clevenger,et al. Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk* , 2001, The Journal of Biological Chemistry.
[10] H. Vora,et al. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] C. Land,et al. A prospective study of estradiol and breast cancer in Japanese women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] A. Levey. Molecules of the Brain , 2000, Hospital practice.
[13] G. Nagy,et al. Prolactin: structure, function, and regulation of secretion. , 2000, Physiological reviews.
[14] B. El-Gamal,et al. Hormonal Profiles and Estrogen Receptors in Egyptian Female Breast Cancer Patients , 2000, Tumori.
[15] C. Clevenger,et al. Prolactin as a chemoattractant for human breast carcinoma. , 1999, Endocrinology.
[16] J. Martial,et al. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Manson,et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.
[18] S. Swan,et al. Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. , 1998, American journal of epidemiology.
[19] P. Kelly,et al. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. , 1998, The Journal of clinical endocrinology and metabolism.
[20] C. Powell,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .
[21] C. Ohlsson,et al. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. , 1997, The Journal of clinical investigation.
[22] R. Blamey,et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. , 1997, The Journal of clinical endocrinology and metabolism.
[23] C. Weinberg,et al. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. , 1995, Epidemiology.
[24] B. Vonderhaar,et al. Prolactin synthesis and secretion by human breast cancer cells. , 1995, Cancer research.
[25] Y. Sinha. Structural variants of prolactin: occurrence and physiological significance. , 1995, Endocrine reviews.
[26] J. Tomaszewski,et al. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. , 1995, The American journal of pathology.
[27] T. Hoffmann,et al. Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance , 1993, Journal of endocrinological investigation.
[28] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[29] B L De Stavola,et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. , 1992, International journal of epidemiology.
[30] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[31] P. Newcomb,et al. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer , 1991, Cancer.
[32] S. de Placido,et al. Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. , 1990, British Journal of Cancer.
[33] D. Ingram,et al. Prolactin and breast cancer risk , 1990, The Medical journal of Australia.
[34] U. Lewis,et al. Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay. , 1990, The Journal of clinical endocrinology and metabolism.
[35] M. Soules,et al. Variability of serum prolactin and progesterone levels in normal women: The relevance of single hormone measurements in the clinical settings , 1990, Obstetrics and gynecology.
[36] C. Chute,et al. Effect of transport conditions on the stability of biochemical markers in blood. , 1989, Clinical chemistry.
[37] J. Bonneterre,et al. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer. , 1986, European journal of cancer & clinical oncology.
[38] A. Morrison,et al. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. , 1986, Journal of the National Cancer Institute.
[39] H. Imura,et al. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. , 1985, Japanese journal of cancer research : Gann.
[40] L. Murphy,et al. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. , 1984, Cancer research.
[41] S. Yen,et al. Pituitary hormone release in response to food ingestion: evidence for neuroendocrine signals from gut to brain. , 1983, The Journal of clinical endocrinology and metabolism.
[42] B. Rosner. Percentage Points for a Generalized ESD Many-Outlier Procedure , 1983 .
[43] J. Bonneterre,et al. Prolactin receptors in human breast cancer. , 1982, European journal of cancer & clinical oncology.
[44] D. Rose,et al. Plasma prolactin levels in patients with breast cancer , 1981, Cancer.
[45] M. Renaer. Reproductive endocrinology physiology, pathophysiology and clinical management , 1979 .
[46] W. Malarkey,et al. Disordered nocturnal prolactin regulation in women with breast cancer. , 1977, Cancer research.
[47] Lachelin Gc,et al. Hormonal changes following hypophysectomy in humans. , 1977 .
[48] E. N. Cole,et al. Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer. , 1977, European journal of cancer.
[49] L. Braverman,et al. Lactation after incision on the thoracic cage. , 1966, The New England journal of medicine.
[50] S. Bender. REPRODUCTIVE ENDOCRINOLOGY , 1955, Current opinion in obstetrics & gynecology.
[51] T. Nemoto,et al. Prolactin binding by human mammary carcinoma: Relationship to estrogen receptor protein concentration and patient age , 2005, Breast Cancer Research and Treatment.
[52] S. Nass,et al. The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.
[53] L. Schuler,et al. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. , 2003, Oncogene.
[54] L. Schuler,et al. PRL modulates cell cycle regulators in mammary tumor epithelial cells. , 2002, Molecular endocrinology.
[55] C. Longcope,et al. A prospective study of endogenous hormones and breast cancer. , 1994, Cancer detection and prevention.
[56] A. Schally,et al. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. , 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[57] W. Kalk,et al. Serum prolactin after chest wall surgery: elevated levels after mastectomy. , 1981, The Journal of clinical endocrinology and metabolism.